Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS)
CNY 15.98
(-0.06%)
CNY 15.98
(-0.06%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 56.81 Million CNY | -16.38% |
| 2022 | 77.53 Million CNY | -34.05% |
| 2021 | 131.45 Million CNY | 115.96% |
| 2020 | 55.05 Million CNY | 1216.93% |
| 2019 | -23.38 Million CNY | -486.12% |
| 2018 | -8.17 Million CNY | 92.93% |
| 2017 | -17.56 Million CNY | 69.28% |
| 2016 | -46.65 Million CNY | -27.05% |
| 2015 | -36.71 Million CNY | -139.97% |
| 2014 | -15.3 Million CNY | 2.28% |
| 2013 | -15.65 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 6.88 Million CNY | 157.21% |
| 2024 Q1 | -33.37 Million CNY | -434.5% |
| 2024 Q3 | 36.17 Million CNY | 303.06% |
| 2023 Q4 | 6.66 Million CNY | 134.41% |
| 2023 Q3 | -19.38 Million CNY | -135.12% |
| 2023 FY | - CNY | -16.38% |
| 2023 Q1 | 5.69 Million CNY | 363.52% |
| 2023 Q2 | 55.19 Million CNY | 869.81% |
| 2022 Q2 | 64.18 Million CNY | 973.11% |
| 2022 Q1 | -7.35 Million CNY | -119.27% |
| 2022 FY | - CNY | -34.05% |
| 2022 Q4 | 1.22 Million CNY | -88.92% |
| 2022 Q3 | 11.07 Million CNY | -82.74% |
| 2021 Q2 | 36.26 Million CNY | 37.34% |
| 2021 Q4 | 38.15 Million CNY | 24.63% |
| 2021 Q1 | 26.4 Million CNY | 116.16% |
| 2021 FY | - CNY | 115.96% |
| 2021 Q3 | 30.61 Million CNY | -15.59% |
| 2020 Q2 | 14.64 Million CNY | 375.37% |
| 2020 FY | - CNY | 1216.93% |
| 2020 Q3 | 186.97 Million CNY | 1176.57% |
| 2020 Q4 | -163.38 Million CNY | -187.38% |
| 2020 Q1 | 3.08 Million CNY | 102.19% |
| 2019 Q1 | 9.4 Million CNY | 0.0% |
| 2019 FY | - CNY | -486.12% |
| 2019 Q4 | -140.62 Million CNY | 0.0% |
| 2018 Q1 | 2.65 Million CNY | -57.93% |
| 2018 Q2 | 2.65 Million CNY | 0.0% |
| 2018 FY | - CNY | 92.93% |
| 2017 Q4 | 6.31 Million CNY | 0.0% |
| 2017 FY | - CNY | 69.28% |
| 2017 Q1 | -4.41 Million CNY | 72.22% |
| 2017 Q3 | 6.31 Million CNY | 243.03% |
| 2017 Q2 | -4.41 Million CNY | 0.0% |
| 2016 Q1 | -7.42 Million CNY | 30.55% |
| 2016 Q4 | -15.9 Million CNY | 0.0% |
| 2016 FY | - CNY | -27.05% |
| 2016 Q3 | -15.9 Million CNY | -114.2% |
| 2016 Q2 | -7.42 Million CNY | -0.0% |
| 2015 Q3 | -10.68 Million CNY | -39.37% |
| 2015 Q2 | -7.66 Million CNY | 0.0% |
| 2015 Q1 | -7.66 Million CNY | 0.0% |
| 2015 FY | - CNY | -139.97% |
| 2015 Q4 | -10.68 Million CNY | 0.0% |
| 2014 FY | - CNY | 2.28% |
| 2013 FY | - CNY | 0.0% |